.jpg)
.png)
NLA News
THOUSAND OAKS, Calif., Oct. 6, 2025 /PRNewswire/ -- Amgen (NASDAQ: AMGN) today announced the launch of AmgenNow, a new direct-to-patient program starting with Repatha® (evolucumab). This follows landmark results demonstrating Repatha significantly reduced the risk... more
Are you attending the AHA Scientific Sessions in Orlando? We have put together a list of relevant sessions and presentations that may be of interest to you. Many of these sessions, including the NLA Master’s Summit on HoFH, feature NLA members as presenters or moderators.... more
Order Dyslipidemia GUIDELINES Pocket Card Part 1 and Part 2. Pocket cards include: Key Points, Lifestyle, General Management, Risk Assessment, Treatment Recommendations, Hypercholesterolemia, Algorithms, Charts, and Tables on Risk Calculators, Criteria for Classification for ASCVD, and more. Choose... more
W. Virgil Brown, MD, FNLA and Ernst J. Schaefer, MD, FNLA, chairs of the Donald S. Fredrickson Conferences and Webinars on Familial Lipoprotein Disorders, are accepting case submissions for an upcoming webinar. The deadline for submissions is Sunday, September 30. If a case is... more
Denver-area clinical pharmacist assumes role during NLA virtual business meeting JACKSONVILLE, Fla. — Joseph J. Saseen, PharmD, CLS, FNLA, officially assumed the role of National Lipid Association (NLA) President at the NLA’s annual virtual business meeting on Monday, June 8, 2020 after serving... more
Kowa Research Institute, Inc. has announced the decision to not continue its Phase 3 PROMINENT study. Read the press release. Kowa has indicated that full data will be shared at a future conference. more
CHICAGO — In this video, James A. Underberg, MD, discusses recommendations from the National Lipid Association for patient-centric management of cholesterol abnormalities, and how they connect with the results of the IMPROVE-IT trial presented at the American Heart Association Scientific... more
CINCINNATI, Ohio – December 15, 2025 – LIB Therapeutics Inc. (LIB), a privately held biopharmaceutical company with a singular focus on helping high-risk patients achieve their cholesterol goals, today announced the U.S. Food and Drug Administration (FDA) has approved LEROCHOL™ (lerodalcibep-... more
The American Academy of Pediatrics recently released an update to its Recommendations for Preventive Pediatric Health Care, also known as the periodicity schedule, which will publish in the January 2016 issue of Pediatrics (published online Dec. 7). Among the updates is a new recommendation that... more
The National Lipid Association is proud to announce the first-ever NLA Junior Faculty Research Award. The purpose of the award is to encourage scholarly advancement of Junior Faculty in the pursuit of a career related to hyperlipidemia and other lipid disorders in humans. The award... more